An assessment of ONRAB oral rabies vaccine persistence in free-ranging mammal populations in Ontario, Canada (Q43874554)

27 November 2017

title

An assessment of ONRAB oral rabies vaccine persistence in free-ranging mammal populations in Ontario, Canada (English)

1 reference

27 November 2017

0 references

1 reference

K G Sobey

1

1 reference

27 November 2017

A A Walpole

2

1 reference

27 November 2017

R Rosatte

3

1 reference

27 November 2017

C Fehlner-Gardiner

4

1 reference

27 November 2017

D Donovan

5

1 reference

27 November 2017

P Bachmann

6

1 reference

27 November 2017

S Coulson

7

1 reference

27 November 2017

A Beresford

8

1 reference

27 November 2017

L Bruce

9

1 reference

27 November 2017

C J Kyle

10

1 reference

27 November 2017

language of work or name

English

0 references

publication date

13 March 2013

1 reference

27 November 2017

1 reference

27 November 2017

volume

31

1 reference

27 November 2017

issue

17

1 reference

27 November 2017

page(s)

2207-2213

1 reference

The ascension of wildlife rabies: a cause for public health concern or intervention?

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Infectious disease and the conservation of free-ranging large carnivores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Emerging infectious diseases of wildlife--threats to biodiversity and human health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Rabies: epidemiology, pathogenesis, and prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Spatial dynamics and molecular ecology of North American rabies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Epidemiology and control of fox rabies in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Prevalence of tetracycline and rabies virus antibody in raccoons, skunks, and foxes following aerial distribution of V-RG baits to control raccoon rabies in Ontario, Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Rabies challenge of captive striped skunks (Mephitis mephitis) following oral administration of a live vaccinia-vectored rabies vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Era vaccine-derived cases of rabies in wildlife and domestic animals in Ontario, Canada, 1989-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Aerial distribution of ONRAB baits as a tactic to control rabies in raccoons and striped skunks in Ontario, Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

High-Density Baiting with ONRAB® Rabies Vaccine Baits to Control Arctic-Variant Rabies in Striped Skunks in Ontario, Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Oral rabies vaccination of raccoons and striped skunks with ONRAB® baits: multiple factors influence field immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Comparing ONRAB® AND RABORAL V-RG® oral rabies vaccine field performance in raccoons and striped skunks, New Brunswick, Canada, and Maine, USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Wild carnivore acceptance of baits for delivery of liquid rabies vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Real‐Time Polymerase Chain Reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: a comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Evaluation and significance of tetracycline stability in rabies vaccine baits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

Human adenovirus type 5 vectors expressing rabies glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.057

10.1016/J.VACCINE.2013.02.057

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference